Jennison Associates
GOSS icon

Jennison Associates’s Gossamer Bio GOSS Stock Holding History

Jennison Associates’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-18,224
Closed -$14.1M – 697
2020
Q4 		$14.1M Sell
18,224
-234
-1% -$184K 0.01% 376
2020
Q3 		$18.3M Buy
18,458
+67
+0.4% +$71.1K 0.01% 314
2020
Q2 		$19.1M Buy
18,391
+9,523
+107% +$9.6M 0.02% 302
2020
Q1 		$7.2M Buy
8,868
+1,302
+17% +$1.36M 0.01% 369
2019
Q4 		$9.46M Hold
7,566
– – 0.01% 385
2019
Q3 		$10.2M Sell
7,566
-679
-8% -$1.08M 0.01% 396
2019
Q2 		$14.6M Sell
8,245
-19
-0.2% -$29.1K 0.01% 393
2019
Q1 		$14.3M Buy
+8,264
New +$13.8M 0.01% 404

Other funds holding GOSS

HHLR Advisors
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Omega Fund Management
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Boxer Capital
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Palo Alto Investors
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Octagon Capital Advisors
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Jennison Associates's GOSS Position: Q1 2021 in Review

Jennison Associates sold out of Gossamer Bio (GOSS) in Q1 2021, closing a stake of 18,224 shares — an estimated $14.1M sold.

Jennison Associates first reported a position in GOSS in Q1 2019 and held it in 8 quarters. The position peaked at $19.1M in Q2 2020. 123 funds tracked by Wall St. Rank hold GOSS as of Q1 2021.

  • Jennison Associates reported no remaining Gossamer Bio position as of Q1 2021 after selling out during the quarter.
  • Jennison Associates sold 18,224 Gossamer Bio shares in Q1 2021, an estimated $14.1M.
  • Jennison Associates first reported a position in Gossamer Bio in Q1 2019 and held it in 8 quarters.
  • Jennison Associates's Gossamer Bio position peaked at $19.1M in Q2 2020.
  • 123 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2021.

Based on Jennison Associates's 13F filing for Q1 2021, filed 11 May 2021.